Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03863509 · ClinicalTrials.gov registry record
E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 450
- Enrollment target
NCT03863509 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 450 participants.
The verdict
NCT03863509 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 450 participants
- Enrollment target
Study Summary
This study is designed to enhance the understanding of the possible health effects of e-cigarette use by relating the acute and long-term use of e-cigarettes and conventional cigarettes ("products") to well-validated cardiovascular and pulmonary disease biomarkers. Participants will be enrolled in 3 groups: exclusive e-cigarette users, exclusive cigarette smokers, and a control group of never-users. Participants can expect up to 4 weeks of study participation.
Interventions
- BEHAVIORAL Cigarettes
- BEHAVIORAL E-Cigarettes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2019-03-05 |
| Est. Completion | 2022-03-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03863509
The ClinicalTrials.gov registry entry for NCT03863509 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cigarettes is the first listed.
NCT03863509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03863509 about?
NCT03863509 is a clinical study titled "E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease". This study is designed to enhance the understanding of the possible health effects of e-cigarette use by relating the acute and long-term use of e-cigarettes and conventional cigarettes ("products") to well-validated cardiovascular and pulmonary disease biomarkers. Participants will be enrolled in 3...
What is the current status of trial NCT03863509?
This trial is currently completed. The enrollment target is 450 participants. The study started on 2019-03-05. Estimated completion is 2022-03-09.
What interventions are being tested in trial NCT03863509?
The interventions under investigation include: Cigarettes (BEHAVIORAL), E-Cigarettes (BEHAVIORAL).
Who is sponsoring clinical trial NCT03863509?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.